Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

Top 10 Stocks Jim Cramer Is Watching Right Now

by Global Market Bulletin
February 27, 2026
in Stock Market News
0
Top 10 Stocks Jim Cramer Is Watching Right Now

Top 10 Stocks Jim Cramer Is Watching Right Now

77
SHARES
167
VIEWS
Share on FacebookShare on Twitter

7. Yum! Brands Inc. (NYSE:YUM)

Yum! Brands, Inc. continues to attract bullish attention as a high-quality restaurant stock, recently trading near $168.51 and building momentum in the consumer discretionary sector. The company, which franchises global quick-service brands including KFC, Taco Bell, and Pizza Hut, is entering what many investors view as a strategic inflection point following its plan to spin off its pizza business. That restructuring move has drawn public support from Jim Cramer, who recently described Yum! Brands as “a horse lately,” noting its roughly 9% rise and advising investors to hold the stock and buy on any pullback. Cramer emphasized that shedding Pizza Hut could unlock stronger reported numbers, particularly as Taco Bell’s performance becomes more visible.

You might also like

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

The spin-off is widely interpreted as a value-unlocking catalyst. By narrowing focus and allowing Taco Bell’s growth profile to stand out, Yum! Brands may drive improved earnings clarity, margin expansion, and higher valuation multiples. Taco Bell has been one of the strongest performers in the fast food industry, benefiting from menu innovation, digital ordering growth, pricing power, and robust same-store sales. As the company streamlines its portfolio, investors gain a clearer view of its highest-return assets, reinforcing the long-term bull case for YUM stock.

Yum! Brands’ asset-light, franchise-driven model supports steady free cash flow, global unit expansion, and consistent dividend growth, positioning it as both a defensive and growth-oriented investment. In an environment where investors favor focused business models and scalable international brands, Yum! Brands combines restructuring upside with durable consumer demand. With endorsement from influential market voices and a strategic plan that highlights Taco Bell’s strength, YUM stock remains a compelling play on global quick-service restaurant growth and shareholder value creation.

Click next to see the following stock...

Page 2 of 8
Prev123...8Next
Tags: American Express Company (NYSE:AXP)Arista Networks Inc (NYSE:ANET)Marriott International Inc. (NASDAQ:MAR)NVIDIA Corporation (NASDAQ:NVDA)Salesforce Inc. (NYSE:CRM)Snowflake Inc. (NYSE:SNOW)The TJX Companies Inc. (NYSE:TJX)Top 10 Stocks Jim Cramer Is Watching Right NowVisa Inc. (NYSE:V)Wells Fargo & Company (NYSE:WFC)Yum! Brands Inc. (NYSE:YUM)
Share31Tweet19

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
June 6, 2026
0
Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Is Bob’s Discount Furniture (BOBS) a Good Retail Stock to Buy for Long-Term Growth?

by Global Market Bulletin
June 6, 2026
0
Is Bob’s Discount Furniture (BOBS) a Good Retail Stock to Buy for Long-Term Growth?

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Here’s What Makes Intellia Therapeutics (NTLA) a High-Risk, High-Reward Stock for Long-Term Investors

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes Intellia Therapeutics (NTLA) a High-Risk, High-Reward Stock for Long-Term Investors

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy
  • Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?
  • Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?